Skip to content

Combination of rapid antimicrobial susceptibility test and antimicrobial stewardship:A method to improve clinical outcome in patient with Gram-negative bacteremia

Combination of rapid antimicrobial susceptibility test and antimicrobial stewardship:A method to improve clinical outcome in patient with Gram-negative bacteremia

Status
Unknown
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241106003
Enrollment
140
Registered
2024-11-06
Start date
2022-10-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gram negative septicemia Gram negative septicemia, Rapid Antimicrobial Susceptibility Testing

Interventions

standard treatment,The Clinical Microbiology Unit in the Laboratory Medicine Department at Srinagarind Hospital routinely performs direct disk diffusion testing directly from culture bottles when gram
s susceptibility to antibiotics such as meropenem, imipenem, ertapenem, ceftazidime-avibactam, sitafloxacin, fosfomycin, cefoperazone-sulbactam, ceftriaxone, ceftazidime, and ciprofloxacin. According
Laboratory Standards Institute (CLSI) guidelines from 2022, laboratories can perform direct disk diffusion testing from culture bottles specifically for Enterobacterales and Pseudomonas aeruginosa. T

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient was 18 years of age or older 2. Hemoculture: Gram negative bacilli at least 1 sample in 24 hours before enrollment

Exclusion criteria

Exclusion criteria: 1. Patient passed away in 24 hours after enrollment 2. Primary doctor rejected the advise of changing the antibiotics from infectious disease doctor

Design outcomes

Primary

MeasureTime frame
Time to optimal targeted antibiotic 72 hours Calculated as the time from detection of Gram-negative bacteria in the blood culture to the initiation of antibiotic therapy with the narrowest-spectrum, most effective agent

Secondary

MeasureTime frame
Mortality rate 28 days Mortality rate

Countries

Thailand

Contacts

Public ContactPawarit Kulwongroj

Faculty of Medicine, Khon Kaen University

Pavara@kku.ac.th0655366455

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026